Literature DB >> 17273115

Oxygen treatment restores energy status following experimental neonatal hypoxia-ischemia.

John W Calvert1, John H Zhang.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether oxygen treatment could attenuate the alterations in cerebral energy metabolism found in the brain following hypoxia-ischemia.
DESIGN: Seven-day-old rat pups were subjected to unilateral carotid artery ligation followed by 2 hrs of hypoxia (8% oxygen at 37 degrees C). The concentrations of high-energy phosphate compounds and glycolytic intermediates and the activity of Na+/K+-adenosine triphosphatase were measured at 4-72 hrs of recovery. Brain weight was used to determine the severity of the brain injury at 2 wks after insult.
SETTING: Experimental setting.
SUBJECTS: Rat pups.
INTERVENTIONS: Pups were treated with 100% oxygen 1 hr after the insult at 2.5 atmospheres absolute (hyperbaric oxygen) or at normobaric pressure for a duration of 2 hrs.
MEASUREMENTS AND MAIN RESULTS: During the initial period of recovery from hypoxia-ischemia, values of adenosine triphosphate and phosphocreatine remained at levels below normal, whereas the levels of glucose and other glycolytic intermediates were elevated. Hyperbaric oxygen and normobaric oxygen both attenuated brain injury, restored the levels of adenosine triphosphate and phosphocreatine, decreased the levels of the glycolytic intermediates, and increased the utilization of energy.
CONCLUSIONS: These results suggest that oxygen treatment during the initial period of recovery from a hypoxia-ischemic insult is able to attenuate energy deficits in the brain, which ultimately leads to a reduction in brain injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273115     DOI: 10.1097/01.PCC.0000257113.75488.84

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  8 in total

1.  Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD+/Sirt1 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats.

Authors:  Qin Hu; Anatol Manaenko; Hetao Bian; Zongduo Guo; Jun-Long Huang; Zhen-Ni Guo; Peng Yang; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2017-05-11       Impact factor: 7.914

2.  Perspectives on neonatal hypoxia/ischemia-induced edema formation.

Authors:  Diana Carolina Ferrari; Olivera Nesic; Jose Regino Perez-Polo
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

3.  Beneficial effect of hyperbaric oxygenation after neonatal germinal matrix hemorrhage.

Authors:  Tim Lekic; Anatol Manaenko; William Rolland; Robert P Ostrowski; Kelly Virbel; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Rapid conditioning with oxygen oscillation: neuroprotection by intermittent normobaric hyperoxia after transient focal cerebral ischemia in rats.

Authors:  Changsuo Liu; John Weaver; Ke Jian Liu
Journal:  Stroke       Date:  2011-10-20       Impact factor: 7.914

5.  Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release.

Authors:  Zhong-jin Yang; Yan Xie; Geraldo M Bosco; Chung Chen; Enrico M Camporesi
Journal:  Eur J Appl Physiol       Date:  2009-10-23       Impact factor: 3.078

6.  Hyperbaric oxygen treatment in autism spectrum disorders.

Authors:  Daniel A Rossignol; James J Bradstreet; Kyle Van Dyke; Cindy Schneider; Stuart H Freedenfeld; Nancy O'Hara; Stephanie Cave; Julie A Buckley; Elizabeth A Mumper; Richard E Frye
Journal:  Med Gas Res       Date:  2012-06-15

7.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

8.  Monitoring of cerebral blood flow during hypoxia-ischemia and resuscitation in the neonatal rat using laser speckle imaging.

Authors:  Thomas Wood; Elisa Smit; Elke Maes; Damjan Osredkar; Mari Falck; Maja Elstad; Marianne Thoresen
Journal:  Physiol Rep       Date:  2016-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.